XML 37 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity
9 Months Ended
Sep. 30, 2014
Equity [Abstract]  
Equity
Equity
The following table provides a reconciliation of total equity for the nine months ended September 30, 2014:
(Dollars in thousands, except per share data)
Common
Stock
Additional
Paid-In
Capital
Accumulated
Other
Comprehensive
Income
Cumulative
Net
Income Attributable to Common Stockholders
Cumulative
Dividends
Total
Stockholders’
Equity
Non-controlling Interests
Total
Equity
Balance at December 31, 2013
$
959

$
2,325,228

$
51

$
808,362

$
(1,891,123
)
$
1,243,477

$
1,809

$
1,245,286

Issuance of common stock
21

52,677




52,698


52,698

Common stock redemptions

(382
)



(382
)

(382
)
Stock-based compensation
1

3,399




3,400


3,400

Net income



13,814


13,814

313

14,127

Dividends to common stockholders ($0.90 per share)




(86,923
)
(86,923
)

(86,923
)
Distributions to non-controlling interests






(510
)
(510
)
Purchase of noncontrolling interest in consolidated partnership

(6,577
)



(6,577
)
(1,612
)
(8,189
)
Balance at September 30, 2014
$
981

$
2,374,345

$
51

$
822,176

$
(1,978,046
)
$
1,219,507

$

$
1,219,507



The following schedule discloses the effects of changes in the Company's ownership interest in its less-than-wholly-owned subsidiary on the Company's stockholders' equity (in thousands):
 
Nine Months Ended September 30, 2014
Net income attributable to common stockholders
$
13,814

Transfers to noncontrolling interest:
 
Net decrease in the Company's additional paid-in capital for purchase of subsidiary partnership interest
(6,577
)
Net transfers to the noncontrolling interest
(6,577
)
Change to the Company's total stockholders' equity from net income attributable to common stockholders and transfers to noncontrolling interest
$
7,237


 

Common Stock    
The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the nine months ended September 30, 2014 and the year ended December 31, 2013:
 
September 30, 2014
 
December 31, 2013
Balance, beginning of period
95,924,339

 
87,514,336

Issuance of common stock
2,149,976

 
8,293,369

Nonvested share-based awards, net
44,231

 
116,634

Balance, end of period
98,118,546

 
95,924,339



At-The-Market Equity Offering Program
During the nine months ended September 30, 2014, the Company sold 2,099,380 shares of common stock under its at-the-market equity offering program, generating $51.8 million in net proceeds at prices ranging from $24.35 to $25.84 per share (weighted average of $25.05 per share). Of this amount, the Company sold 999,080 shares of common stock during the third quarter of 2014 generating $24.5 million in net proceeds at prices ranging from $24.35 to $25.50 per share (weighted average of $24.93 per share). In October 2014, the Company sold 58,504 shares of common stock, generating $1.5 million in net proceeds at prices ranging from $25.00 to $25.35 per share (weighted average of $25.32 per share).

The Company's existing sales agreements with four investment banks allow sales under this program of up to 9,000,000 shares of common stock, with 3,233,516 authorized shares remaining available to be sold under the these agreements as of November 4, 2014.

Common Stock Dividends
During the first nine months of 2014, the Company declared and paid common stock dividends totaling $0.90 per share.
On November 4, 2014, the Company declared a quarterly common stock dividend in the amount of $0.30 per share payable on November 28, 2014 to stockholders of record on November 14, 2014.

Earnings (Loss) Per Common Share
The following table sets forth the computation of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2014 and 2013.
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(Dollars in thousands, except per share data)
2014
 
2013
 
2014
 
2013
Weighted average Common Shares outstanding
 
 
 
 
 
 
 
Weighted average Common Shares outstanding
97,651,673

 
95,220,031

 
96,677,774

 
91,665,703

Nonvested shares
(1,793,639
)
 
(1,777,203
)
 
(1,832,242
)
 
(1,794,606
)
Weighted average Common Shares outstanding—Basic
95,858,034

 
93,442,828

 
94,845,532

 
89,871,097

Weighted average Common Shares—Basic
95,858,034

 
93,442,828

 
94,845,532

 
89,871,097

Dilutive effect of restricted stock
1,369,047

 
1,278,902

 
1,346,032

 

Dilutive effect of employee stock purchase plan
101,963

 
114,264

 
118,854

 

Weighted average Common Shares outstanding—Diluted
97,329,044

 
94,835,994

 
96,310,418

 
89,871,097

Net Income (Loss)
 
 
 
 
 
 
 
Income (loss) from continuing operations
$
8,537

 
$
4,614

 
$
25,233

 
$
(22,372
)
Noncontrolling interests’ share in net (income) loss
(162
)
 
(18
)
 
(313
)
 
34

Income (loss) from continuing operations attributable to common stockholders
8,375

 
4,596

 
24,920

 
(22,338
)
Discontinued operations
(4,384
)
 
15,169

 
(11,106
)
 
16,899

Net income (loss) attributable to common stockholders
$
3,991

 
$
19,765

 
$
13,814

 
$
(5,439
)
Basic Earnings (Loss) Per Common Share

 

 
 
 
 
Income (loss) from continuing operations
$
0.09

 
$
0.05

 
$
0.27

 
$
(0.25
)
Discontinued operations
(0.05
)
 
0.16

 
(0.12
)
 
0.19

Net income (loss) attributable to common stockholders
$
0.04

 
$
0.21

 
$
0.15

 
$
(0.06
)
Diluted Earnings (Loss) Per Common Share

 

 
 
 
 
Income (loss) from continuing operations
$
0.09

 
$
0.05

 
$
0.26

 
$
(0.25
)
Discontinued operations
(0.05
)
 
0.16

 
(0.12
)
 
0.19

Net income (loss) attributable to common stockholders
$
0.04

 
$
0.21

 
$
0.14

 
$
(0.06
)


The effect of 1,294,953 nonvested shares and options to purchase 164,418 shares of the Company's common stock for the nine months ended September 30, 2013 were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during that period.

Incentive Plans
The Company has various stock-based incentive plans for its employees and directors. Awards under these plans include nonvested common stock issued to employees and the Company’s directors. During the nine months ended September 30, 2014 and 2013, the Company issued 128,199 and 87,043 shares of nonvested common stock, respectively, to participants under these incentive plans and withheld 16,170 and 9,433 shares of common stock, respectively, from participants to pay estimated withholding taxes related to shares that vested.

A summary of the activity under the stock-based incentive plans for the three and nine months ended September 30, 2014 and 2013 is included in the table below.
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2014
 
2013
 
2014
 
2013
Stock-based awards, beginning of period
1,837,855

 
1,778,083

 
1,788,168

 
1,770,061

Granted

 

 
128,199

 
87,043

Vested
(4,911
)
 
(890
)
 
(83,423
)
 
(79,911
)
Forfeited
(67,798
)
 

 
(67,798
)
 

Stock-based awards, end of period
1,765,146

 
1,777,193

 
1,765,146

 
1,777,193



The Company recorded approximately $0.2 million in general and administrative expenses during the first quarter of 2014 relating to the annual grant of options to its employees under the Employee Stock Purchase Plan based on the Company's estimate of option exercises.

A summary of the activity under the Employee Stock Purchase Plan for the three and nine months ended September 30, 2014 and 2013 is included in the table below.
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2014
 
2013
 
2014
 
2013
Outstanding and exercisable, beginning of period
440,471

 
433,801

 
391,108

 
433,452

Granted

 

 
275,655

 
246,717

Exercised
(11,668
)
 
(7,478
)
 
(40,988
)
 
(60,483
)
Forfeited
(5,219
)
 
(14,007
)
 
(44,316
)
 
(36,819
)
Expired

 

 
(157,875
)
 
(170,551
)
Outstanding and exercisable, end of period
423,584

 
412,316

 
423,584

 
412,316